James S. Scibetta, President at Pacira Pharmaceuticals, Inc. (PCRX), sold 3,932 shares at $43.32 ($170K) on 2017-06-05, disclosed to the SEC on 2017-06-07.
Open-market sale of $170k PCRX by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.32 | 1,966 | $85K | 50.0% |
| 2 | $43.32 | 1,966 | $85K | 50.0% |
| Total | $43.32 avg | 3,932 | $170K | 100% |
| Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |
| PCRX | SELL | 2016-11-17 | $730K | — | Filing → |